FIELD: medicine, pharmaceutics.SUBSTANCE: there are presented a method of treating post-traumatic stress disorder, a method of improving a resistance to any symptom of post-traumatic stress disorder, a diagnostic technique for post-traumatic stress disorder, all using (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)amide 4-hydroxy-4-methylpiperidine-1-carboxylic acid, a based pharmaceutical composition for treating a patient diagnosed with post-traumatic stress disorder.EFFECT: what is shown is eliminating stress-induced anhedonia and relieving APEC-induced decreased motion activity by (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)amide 4-hydroxy-4-methylpiperidine-1-carboxylic acid.21 cl, 12 ex
(4-METHOXY-7-MORPHOLIN-4-YL-BENZOTHIAZOL-2-YL)AMIDE 4-HYDROXY-4-METHYLPIPERIDINE-1-CARBOXYLIC ACID FOR TREATING POST-TRAUMATIC STRESS DISORDER